Bone and Cancer Working Group

Members

Chair: R Rizzoli     
Members: E Biver, JJ Body, ML Brandi, C Campusano, J Cannata-Andia, M Chakhtoura, C Confavreux, P Ebeling, G El Hajj Fuleihan, A El Maghraoui, J Foldes, C Glüer, G Guglielmi, P Hadji, G Holzer, D Kendler, N Napoli, A Papaioannou, T de Villiers

Aim

To define and assess the effects on bones following a cancer or cancer treatment.

Projects

  • Optimal duration of BTAs (bone targeting agent) administration in patients with tumour bone diseases
  • Evaluation of fracture risk in bone metastasis
  • Bone metabolism in monoclonal gammopathy and multiple myeloma
  • Primary malignant bone tumours and bone health

Publications

Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors.
Marcucci G, Beltrami G, Tamburini A,  Body J J, Confavreux C B, Hadji P,  Holzer G, Kendler D, Napoli N,  Pierroz DD,  Rizzoli R, Brandi ML on behalf of the International Osteoporosis Foundation Cancer and Bone Working Group. Annals of Oncology, mdz120, https://doi.org/10.1093/annonc/mdz120
https://academic.oup.com/annonc/advance-article/doi/10.1093/annonc/mdz120/5492552

Bone management in hematologic stem cell transplant recipients. 
Kendler, D., Body, J., Brandi, M. et al. for the International Osteoporosis Foundation Committee of Scientific Advisors Working Group on Cancer and Bone Disease. Osteoporosis International (2018). DOI 10.1007/s00198-018-4669-4 https://link.springer.com/article/10.1007%2Fs00198-018-4669-4

The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the International Osteoporosis Foundation. 
Cianferotti, L., Bertoldo, F., Carini, M. et al. Oncotarget (2017). DOI 10.18632/oncotarget.17980 https://doi.org/10.18632/oncotarget.17980

Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG. 
Hadji, P., Aapro, M., Body, J. et al. Journal of Bone Oncology (2017). DOI 10.1016/j.jbo.2017.03.001 
https://www.sciencedirect.com/science/article/pii/S2212137417300258

Cancer-associated bone disease
Rizzoli, R., Body, J., Brandi, M. et al. for the International Osteoporosis Foundation Committee of Scientific Advisors Working Group on Cancer-Induced Bone Disease. Osteoporosis International (2013). DOI 10.1007/s00198-013-2530-3 http://link.springer.com/article/10.1007/s00198-013-2530-3